Angelo Avogaro
University of Padua
Internal medicineEndocrinologySurgeryCardiologyChemistryProgenitor cellImmunologyEndotheliumType 2 diabetesInsulin resistanceDiseaseInsulinHypoglycemiaType 1 diabetesStem cellPopulationType 2 Diabetes MellitusDiabetes mellitusMedicineBiology
646Publications
95H-index
19.5kCitations
Publications 651
Newest
#1Raffaella Buzzetti (Sapienza University of Rome)H-Index: 56
#2Riccardo C. Bonadonna (University of Parma)H-Index: 64
view all 11 authors...
Source
#1Mattia Albiero (UNIPD: University of Padua)H-Index: 31
#2Marianna D’Anna (UNIPD: University of Padua)H-Index: 5
Last. Gian Paolo Fadini (UNIPD: University of Padua)H-Index: 67
view all 9 authors...
Aims. Peripheral artery disease (PAD) is a severe complication of diabetes, characterized by defective traffic of hematopoietic stem/progenitor cells (HSPCs). We examined the hematopoietic versus n...
Source
#1Mario Luca Morieri (UNIPD: University of Padua)H-Index: 12
#2Giovanni TargherH-Index: 83
Last. Angelo Avogaro (UNIPD: University of Padua)H-Index: 95
view all 11 authors...
Abstract null null Aims null Metabolic dysfunction-associated fatty liver disease (MAFLD) is common in people with type 2 diabetes (T2D) and can progress to advanced fibrosis and cirrhosis. In this retrospective study, we explored the longitudinal changes in markers of hepatic steatosis and fibrosis during T2D treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs). null null null Methods null We analysed observational data from six diabetes outpatient clinics. In the whole T2D popul...
Source
#1Enrico Longato (UNIPD: University of Padua)H-Index: 6
#2Benedetta Maria Bonora (UNIPD: University of Padua)H-Index: 17
Last. Gian Paolo Fadini (UNIPD: University of Padua)H-Index: 67
view all 7 authors...
Abstract null null Aims null We compared cardiovascular outcomes of patients with type 2 diabetes (T2D) receiving sodium glucose cotransporter-2 inhibitors (SGLT2i) or dipeptidyl peptidase-4 inhibitors (DPP4i) under routine care. null null null Methods null From an administrative claims database of >5,2M citizen, we identified patients with T2D who initiated SGLT2i or DPP4i from 2014 to 2018. Patients were matched by propensity scores. The primary outcome was the 3-point major adverse cardiovasc...
Source
#1Raffaele NapoliH-Index: 30
#2Angelo Avogaro (UNIPD: University of Padua)H-Index: 95
Last. Agostino Consoli (University of Chieti-Pescara)H-Index: 34
view all 7 authors...
Abstract null null Patients with type 2 diabetes mellitus (T2DM) show an increased risk of cardiovascular diseases (CVD) and mortality. Many factors are implicated in the pathogenesis of CVD in patients with T2DM. Among the factors involved, chronic hyperglycemia and the cluster of CVD risk factors, such as dyslipidemia, hypertension, and obesity, appear to play a major role. For many years, the control of hyperglycemia has been complicated by the fact that the use of many available drugs was as...
1 CitationsSource
#1Benedetta Maria Bonora (UNIPD: University of Padua)H-Index: 17
#2Mattia Albiero (UNIPD: University of Padua)H-Index: 31
Last. Gian Paolo Fadini (UNIPD: University of Padua)H-Index: 67
view all 10 authors...
In two large RCTs, fenofibrate reduced the progression of diabetic retinopathy. We investigated whether fenofibrate increases circulating haematopoietic stem/progenitor cells (HSPCs), which have vascular properties and have been shown to protect from retinopathy. We conducted a 12 week parallel-group RCT comparing fenofibrate vs placebo. Patients with diabetic retinopathy and without other conditions that would affect HSPCs were enrolled at a tertiary diabetes outpatient clinic and randomised to...
Source
#1Mario Luca Morieri (UNIPD: University of Padua)H-Index: 12
#2Valentina PerroneH-Index: 13
Last. Angelo Avogaro (UNIPD: University of Padua)H-Index: 95
view all 9 authors...
BACKGROUND This cross-sectional study aimed to identify actionable factors to improve LDL-cholesterol target achievement and overcome underuse of lipid-lowering treatments in high- or very-high-cardiovascular risk patients. METHODS We evaluated healthcare records of 934,332 subjects from North-Italy, including subjects with available lipid profile and being on statin treatments up to December 2018. A 6-month-period defined adherence with proportion-of-days-covered ≥ 80%. Treatment was classified...
Source
Source
#1Federico Boscari (UNIPD: University of Padua)H-Index: 16
#2Martina Vettoretti (UNIPD: University of Padua)H-Index: 12
Last. Daniela Bruttomesso (UNIPD: University of Padua)H-Index: 36
view all 9 authors...
AIM To compare accuracy, efficacy and acceptance of implantable and transcutaneous continuous glucose monitoring (CGM) systems. METHODS In a randomized crossover trial we compared 12 weeks with Eversense implantable sensor (EVS) and 12 weeks with Dexcom G5 transcutaneous sensor (DG5) in terms of accuracy, evaluated as Mean Absolute Relative Difference (MARD) vs capillary glucose (SMBG), time of CGM use, adverse events, efficacy (as HbA1c, time in range, time above and below range) and psychologi...
Source
#1Nicola Vitturi (UNIPD: University of Padua)H-Index: 8
#2Livia Lenzini (UNIPD: University of Padua)H-Index: 14
Last. Angelo Avogaro (UNIPD: University of Padua)H-Index: 95
view all 7 authors...
Source